@article{df596808adac4f84998d5b1b876476a8,
title = "Reply to Comment on: Treatment of EBV-Associated Nodular Sclerosing Hodgkin Lymphoma in a Patient With Ataxia Telangiectasia With Brentuximab Vedotin and Reduced COPP Plus Rituximab",
keywords = "Antineoplastic Combined Chemotherapy Protocols/administration \& dosage, Ataxia Telangiectasia/drug therapy, Epstein-Barr Virus Infections/drug therapy, Herpesvirus 4, Human, Hodgkin Disease/drug therapy, Humans, Immunoconjugates/administration \& dosage, Male, Rituximab/administration \& dosage",
author = "Meister, \{Michael T\} and Sandra Voss and Dirk Schwabe",
year = "2016",
month = may,
doi = "10.1002/pbc.25884",
language = "English",
volume = "63",
pages = "947",
journal = "Pediatric blood \& cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "5",
}